Researchers have grown three-dimensional samples of mineralised bone from human mesenchymal stem cells without typical osteoinductive media.
Scientists may not be able to stop fair-skinned redheads from getting sunburnt but they are a step closer to reducing their likelihood of certain types of skin cancer. Researchers from Boston and Edinburgh have found that triggering skin pigmentation in the laboratory can prevent mice from developing melanoma.
UNSW engineers have invented a new architecture for quantum computing that promises to make the large-scale manufacture of quantum chips both cheaper and easier than previously thought possible.
Queensland researchers are a step closer to developing new medicines for treating inflammatory diseases, including allergies such as rhinitis, itchy hives, asthma, eczema and dermatitis.
An international team of researchers from Australia, the UK, Malaysia and India are developing a prototype vaccine to minimise the impact of Nipah virus (NiV) on the pig industry.
New Zealand researchers have discovered an unexpected role for a white blood cell called the natural killer (NK) cell — a critical cell for ridding the body of infection and cancer.
A newly released study finds that people living in the Oceania region, including Australia, have the highest risk in the world of having and dying from rheumatic heart disease.
A treatment for deadly peanut allergy has been found to show long-lasting effects, providing what is claimed to be the strongest evidence yet that a cure may be possible for peanut allergy.
Murdoch University joined global energy producer Chevron for the official launch of the Harry Butler Institute, set to shape the next generation of leaders in conservation and environmental management.
With a relentless passion for plants, a strong desire to secure the world's food resources and numerous papers and awards under his belt, Dr Jonathan Plett from Western Sydney University is one of Australia's most promising scientists.
Newly developed methods to produce and analyse genetic mosaics are expected to allow researchers to induce multispectral genetic mosaics in vertebrate models such as mice and zebrafish.
An international research team is studying various types of lizard venom as possible treatments for blood-clotting diseases.
Scientists have identified a first-in-class molecule that shuts down estrogen-sensitive breast cancer.
Two new studies have revealed that the gut bacteria composition affects nutritional choices as well as reproduction, using common fruit flies as a model system.
The Walter and Eliza Hall Institute of Medical Research has made a landmark deal worth up to US$325 million ($408 million) from the partial sale of royalty rights for anticancer treatment venetoclax.